Faruqi & Faruqi Investigating Tvardi Therapeutics Securities Litigation

sábado, 29 de noviembre de 2025, 9:00 am ET1 min de lectura
TVRD--

Faruqi & Faruqi is investigating potential claims against Tvardi Therapeutics, Inc. (NASDAQ: TVRD) regarding significant losses in the company's stock or options. Investors who suffered losses can contact James (Josh) Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for legal rights discussion.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios